Fluorine F 18-EF5
Term · Oncology and biomedicine · MLC-T-ONC-003261
A radioactive substance being studied in positron emission tomography (PET) imaging to find cancer cells that have a low level of oxygen. This may help predict how well the cancer will respond to treatment. Also called 18F-EF5.
A radioconjugate consisting of EF5, a fluorinated derivative of etanidazole, conjugated to fluorine F 18, a positron emitting isotope. EF5 binds to hypoxic tissue; conjugation to Fluorine F 18 allows imaging of hypoxic regions within tumors.
| Identifier | MLC-T-ONC-003261 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | 18F-EF5 |
| Synonyms | 18F-EF5 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-003261",
"term": "Fluorine F 18-EF5",
"field": "Oncology and biomedicine",
"definitions": [
"A radioactive substance being studied in positron emission tomography (PET) imaging to find cancer cells that have a low level of oxygen. This may help predict how well the cancer will respond to treatment. Also called 18F-EF5.",
"A radioconjugate consisting of EF5, a fluorinated derivative of etanidazole, conjugated to fluorine F 18, a positron emitting isotope. EF5 binds to hypoxic tissue; conjugation to Fluorine F 18 allows imaging of hypoxic regions within tumors."
],
"abbreviation": "18F-EF5",
"synonyms": [
"18F-EF5"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/fluorine-f-18-ef5/"
}
Record 7,467 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.